CIM
BIIB icon

Chiron Investment Management’s Biogen BIIB Stock Holding History

Chiron Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-91,096
Closed -$29M – 68
2017
Q4 		$29M Buy
91,096
+31,100
+52% +$9.98M 3.93% 5
2017
Q3 		$18.8M Buy
59,996
+30,996
+107% +$9.18M 3.95% 8
2017
Q2 		$7.87M Buy
+29,000
New +$7.67M 2.34% 20

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Chiron Investment Management's BIIB Position: Q1 2018 in Review

Chiron Investment Management sold out of Biogen (BIIB) in Q1 2018, closing a stake of 91,096 shares — an estimated $29M sold.

Chiron Investment Management first reported a position in BIIB in Q2 2017 and held it in 3 quarters. The position peaked at $29M in Q4 2017. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q1 2018.

  • Chiron Investment Management reported no remaining Biogen position as of Q1 2018 after selling out during the quarter.
  • Chiron Investment Management sold 91,096 Biogen shares in Q1 2018, an estimated $29M.
  • Chiron Investment Management first reported a position in Biogen in Q2 2017 and held it in 3 quarters.
  • Chiron Investment Management's Biogen position peaked at $29M in Q4 2017.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q1 2018.

Based on Chiron Investment Management's 13F filing for Q1 2018, filed 15 May 2018.